DMTKDermTech, Inc.


$ 0.35 $ -0.01 (-2.8 %)    

Tuesday, 21-May-2024 15:03:06 EDT
QQQ $ 454.82 $ 1.17 (0.26 %)
DIA $ 398.57 $ 0.26 (0.06 %)
SPY $ 530.36 $ 1.52 (0.29 %)
TLT $ 91.26 $ -0.19 (-0.21 %)
GLD $ 225.37 $ -0.32 (-0.14 %)
$ 0.3601
$ 0.35
$ 0.00 x 0
$ 0.34 x 100
$ 0.34 - $ 0.37
$ 0.31 - $ 3.90
3,176,727
na
12.5M
$ 2.12
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 dermtech-q1-2024-adj-eps-058-misses-057-estimate-sales-385m-miss-399m-estimate

DermTech (NASDAQ:DMTK) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.57) by...

 lake-street-downgrades-dermtech-to-hold-announces-063-price-target

Lake Street analyst Thomas Flaten downgrades DermTech (NASDAQ:DMTK) from Buy to Hold and announces $0.63 price target.

 stephens--co-reiterates-equal-weight-on-dermtech-maintains-15-price-target

Stephens & Co. analyst Mason Carrico reiterates DermTech (NASDAQ:DMTK) with a Equal-Weight and maintains $1.5 price target.

 btig-downgrades-dermtech-to-neutral

BTIG analyst Sung Ji Nam downgrades DermTech (NASDAQ:DMTK) from Buy to Neutral.

 dermtech-intends-to-continue-laboratory-operations-during-strategic-review

The Company anticipates incurring a one-time restructuring charge of approximately $1.6 million in the second quarter of 2024 i...

 dermtech-to-seek-strategic-alternatives-plans-restructuring-actions-that-will-result-in-workforce-reduction-of-100-employees-or-56-of-workforce

Potential strategic alternatives that may be explored or evaluated include an acquisition, merger, reverse merger, business com...

 btig-maintains-buy-on-dermtech-lowers-price-target-to-2

BTIG analyst Mark Massaro maintains DermTech (NASDAQ:DMTK) with a Buy and lowers the price target from $4 to $2.

 stephens--co-maintains-equal-weight-on-dermtech-lowers-price-target-to-15

Stephens & Co. analyst Mason Carrico maintains DermTech (NASDAQ:DMTK) with a Equal-Weight and lowers the price target fr...

 why-zscaler-shares-are-trading-lower-by-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.

 recap-dermtech-q4-earnings
Recap: DermTech Q4 Earnings
02/29/2024 21:05:18

 dermtech-q4-2023-gaap-eps-0560-beats-0570-estimate-sales-3924m-miss-4044m-estimate

DermTech (NASDAQ:DMTK) reported quarterly losses of $(0.560) per share which beat the analyst consensus estimate of $(0.570) by...

 earnings-scheduled-for-february-29-2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION